Interim CEO at Boule Diagnostics
The board of directors at Boule Diagnostics has today appointed Simonetta Tumbiolo, currently Chief Commercial Officer Diagnostic, as Interim Chief Executive Officer, effective June 1 2026.
As previously communicated, Torben Nielsen will step down from the role of CEO. The appointment of Simonetta Tumbiolo ensures continuity in leadership while the Board conducts a process to appoint a permanent CEO.
Chair statement:
“Simonetta has deep knowledge of the Company and its operations, and the Board has full confidence in her ability to lead the business during this transition,” said Torben Jörgensen, Chairman of the Board at Boule Diagnostics.
Interim CEO statement:
“I am honored to take on the role of Interim CEO and to continue working with our global teams,” said Simonetta. “My priority will be to ensure stability in the business and maintain our strategic direction during this period.”
The Company confirms that its strategy, financial targets, and outlook remain unchanged.
Latest news
-
Kallelse till extra bolagsstämma i Boule Diagnostics AB (publ) 4 Nov, 2026
-
Boule Diagnostics AB resolves on a fully secured rights issue of approximately MSEK 93 with an over-allotment option of up to approximately MSEK 63 subject to approval by the Extraordinary General Meeting 4 Nov, 2026
-
Boule Diagnostics AB beslutar om en fullt säkerställd företrädesemission om cirka 93 MSEK med en övertilldelningsoption om upp till cirka 63 MSEK villkorat av godkännande från extra bolagsstämma 4 Nov, 2026
-
Boule Diagnostics renodlar verksamheten mot förbrukningsvaror, service och OEM – avvecklar instrumentverksamheten 4 Nov, 2026
-
Boule Diagnostics refocuses its operations on consumables, service and OEM – discontinues its instrument business 4 Nov, 2026
-
Boule Diagnostics delårsrapport Q3 2026 23 Oct, 2026
-
Boule Diagnostics Interim Report Q3 2026 23 Oct, 2026
-
Boule Diagnostics Strengthens Long-Term Strategic Collaboration in India 6 Oct, 2026